Capillary electrophersis

DxDirect uses the ABI3500 family of instruments for IVD quality analysis, proven reliability and availability globally in existing laboratories.

Low cost

DxDirect provides an ideal combination of multiplexing, high accuracy, and cost for longitudinal testing of therapy response and disease activity management required more affordable testing methods to become everyday practice.

Up to 80 Plex

DxDirect enables simultaneous measurement of up to 80 targets in a single reaction enabling a rich analysis of multiple immune pathways in a single test.

Rapid turn around

DxDirect chemistry can be run same day only requiring 6 hours of run time allowing for standard patient work up for patients.

Low batch sizes

DxDirect allows small lot sizes to managed economically enabling rapid turn around of single samples crucial for studies which require inclusion criteria.

Eliminates batch effects

Unlike NGS based multiplex testing which suffers from batch effects distorting results across runs, DxDirect has excellent reproducible and stable results for large clinical studies where high accuracy is a priority.